JCR Pharmaceuticals Co., Ltd. (JCRRF)
OTCMKTS · Delayed Price · Currency is USD
4.170
0.00 (0.00%)
At close: Jan 30, 2026
JCR Pharmaceuticals Market Cap
JCR Pharmaceuticals has a market cap or net worth of $538.71 million as of February 12, 2026. Its market cap has increased by 19.43% in one year.
Market Cap
538.71M
Enterprise Value
781.21M
Revenue
239.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
$4.17
Market Cap Chart
Since March 22, 2011, JCR Pharmaceuticals's market cap has increased from 354.85M to 538.71M, an increase of 51.82%. That is a compound annual growth rate of 2.84%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 10, 2026 | 538.71M | -3.07% |
| Dec 30, 2025 | 555.76M | 18.12% |
| Dec 30, 2024 | 470.50M | -54.65% |
| Dec 29, 2023 | 1.04B | -34.76% |
| Dec 30, 2022 | 1.59B | -33.46% |
| Dec 30, 2021 | 2.39B | -18.01% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 805.86M |
| Glass House Brands | 761.25M |
| Elite Pharmaceuticals | 485.68M |
| Northwest Biotherapeutics | 413.38M |
| Nika Pharmaceuticals | 403.38M |
| American Oncology Network | 377.98M |
| OpGen | 337.95M |
| CytoDyn | 304.50M |